CLB - Core Laboratories N.V.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
684,639
700,846
659,809
594,741
797,520
Cost of Revenue
526,315
520,051
499,180
469,516
560,109
Gross Profit
158,324
180,795
160,629
125,225
237,411
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
62,948
62,266
47,737
39,390
49,729
Total Operating Expenses
62,948
62,266
47,737
39,390
49,729
Operating Income or Loss
95,376
118,529
112,892
85,835
187,682
Interest Expense
14,736
13,328
10,734
11,572
12,380
Total Other Income/Expenses Net
-1,769
93
-452
344
-26,612
Income Before Tax
78,871
105,294
101,706
74,607
148,690
Income Tax Expense
-13,717
25,447
18,610
10,748
33,758
Income from Continuing Operations
92,588
79,847
83,096
63,859
114,932
Net Income
100,488
79,526
83,125
63,895
114,847
Net Income available to common shareholders
100,488
79,526
83,125
63,895
114,847
Reported EPS
Basic
-
1.80
1.88
1.47
2.69
Diluted
-
1.79
1.88
1.46
2.68
Weighted average shares outstanding
Basic
-
44,206
44,153
43,479
42,747
Diluted
-
44,474
44,264
43,670
42,908
EBITDA
-
141,709
137,380
113,051
161,070